Skip to content

Category: Biotechnology

Bioxyne (ASX:BXN) Delivers Australia’s First Pharmaceutical Cannabis Gummies Under TGA GMP Licence

By API User

Sydney, Australia – 21 August 2024 | Bioxyne Limited (ASX: BXN) (“Bioxyne” or “the Company”) is proud to announce that its 100% owned subsidiary, Breathe Life Sciences (BLS), has successfully manufactured and delivered Australia’s first pharmaceutical-grade cannabis pastilles (“Gummies” or “Edibles“) under its Good Manufacturing Practice (GMP) certification from the Therapeutic Goods Administration (TGA). This … Continued

Scientists unpack new information on exciting yet “ambiguous” drug receptor

By API User

Researchers have uncovered new clues about a mysterious immune-modulating protein with the ability to resolve inflammation in a variety of diseases including inflammatory bowel diseases, rheumatoid arthritis and those at risk of heart attack. In the preclinical study, published in the prestigious British Journal of Pharmacology, the Monash University team have described significant new insights into … Continued

De Motu Cordis (DMC) Applauds ARS Pharma’s FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts

By API User

Brisbane, QLD – 16 August 2024 – De Motu Cordis (DMC) is pleased to acknowledge and enthusiastically commends the recent U.S. FDA approval of ARS Pharma’s Neffy®, the first-ever needle-free intranasal epinephrine delivery device for the treatment of anaphylaxis. This groundbreaking approval, announced on August 9, represents a significant step forward in expanding emergency treatment … Continued

SPONTAN® Prescribed to First Patients Under the TGA Authorised Prescriber Scheme

By API User

Sydney, Australia – 16 August 2024 | LTR Pharma Limited (ASX: LTP) (“LTR Pharma” or “the Company”) is pleased to announce another milestone in introducing SPONTAN®, its innovative nasal spray treatment for Erectile Dysfunction (ED), to the market. SPONTAN® has now been prescribed to its first patients under the Therapeutic Goods Administration’s (TGA) Authorised Prescriber … Continued

LTR Pharma (ASX:LTP) Secures Global Co-Development Agreement with Aptar Pharma for SPONTAN® Nasal Spray

By API User

Sydney, Australia – 13 August 2024 | LTR Pharma Limited (ASX: LTP) (“LTR Pharma” or “the Company”) is pleased to announce that it has entered into a significant Co-Development Agreement (the “Agreement”) with Aptar Pharma, a global leader in drug delivery systems. This Agreement to collaborate is aimed at accelerating the commercialisation of LTR Pharma’s … Continued

Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities

By API User

Operational complementarities expected to yield annual synergies of approximately $100 million Brings together Recursion’s scaled biology exploration and translational capabilities with Exscientia’s precision chemistry design and small molecule automated synthesis capabilities to create a leading technology-first, end-to-end drug discovery platform Combined business positioned to leverage latest advances in the life sciences and technology to deliver … Continued

SPONTAN® Prescribed by Brisbane Men’s Health Expert Under TGA’s Special Access Scheme

By API User

Sydney, Australia – 8 August 2024 | LTR Pharma Limited (ASX: LTP) (“LTR Pharma” or “the Company”) is pleased to announce that SPONTAN®, its innovative nasal spray treatment for Erectile Dysfunction (ED), has been prescribed by a second men’s health expert in Australia under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS). This milestone … Continued

La Trobe finalist in NASA Deep Space Food competition

By API User

La Trobe University and Gaia Project Australia have been named finalists in NASA’s Deep Space Food Challenge for a project designed to grow food for long space journeys such as the Artemis missions to the moon and Mars. The team created a vertical farm where leafy and micro greens are grown in a controlled environment … Continued

How supercharged silk could help heal the heart

By API User

Engineers at UNSW have weaved their magic to create a new material made of silk that could ultimately help regenerate heart tissue. They have taken silk from a domestic silk moth, turned it into a form of jelly called a microgel using light and shown in mice that it is tolerated in the body and … Continued

BlinkLab Limited (ASX:BB1) Partners with Monash University for Study on the Pharmacology of Human Decision-Making

By API User

Sydney, Australia – 6 August 2024 | BlinkLab Limited (ASX: BB1) (“BlinkLab” or “the Company”) is pleased to announce its new collaboration with Monash University to conduct a study on the pharmacology of human decision-making.  The pioneering study aims to explore how ketamine impacts human cognitive processes, providing insights that could revolutionise the treatment of … Continued